Clinical Trials Logo

Filter by:
NCT ID: NCT01001156 Completed - Clinical trials for The Physiological Alterations of Aging Are Systemic.

Effects of the Breathing Muscular Training of Institutionalized Elderly

Start date: October 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study was to use associated breathing exercises the incentive inspiratory of load lineal pressoric, Threshold® IMT, or of load pressoric alinear, Voldyne®, in institutionalized elderly, comparing the effect of the same ones in the training of the breathing musculature, for the increment of the muscular strength, expressed by the maximum breathing pressures (MIP and MEP). From the total number of admitted people (n = 52), 12 individuals were excluded: one by appearance of cognitive deficit, one by death (stroke), one by visual deficit (glaucoma) and twelve by failure to continue the training. After selecting the sample, the 37 participants were randomly divided into three different groups: the Threshold Group (TG; n = 13, age = 70. 93 ± 8.41 years old, BMI = 24.06 ± 3.69 kg/m²), the Voldyne Group (VG; n = 12, age = 70.54 ± 7. 73 years-old, BMI = 27.17 ± 5.66 kg/m²) and the Control Group (CG; n= 12, age = 73. 92 ± 7.28 years-old, BMI = 24.80 ± 5.42 kg/m²). The TG and VG received treatment with respiratory exercises and Threshold and Voldyne muscular training, respectively. The CG received only respiratory exercises.

NCT ID: NCT01000727 Completed - Clinical trials for Acute Coronary Syndrome

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

SOLID-TIMI 52
Start date: December 2009
Phase: Phase 3
Study type: Interventional

This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or urgent coronary revascularization (e.g. medical procedures performed to restore the normal blood flow in patients with atherosclerosis)) when treatment is started within 30 days after an acute coronary syndrome (also called ACS).

NCT ID: NCT01000402 Recruiting - Bipolar Disorder Clinical Trials

Juvenile Bipolar Disorder Outpatient Program

ProCAB
Start date: February 2008
Phase: Phase 4
Study type: Interventional

This is an outpatient program for children and adolescents with bipolar disorders. The naturalistic approach of the program will allow a proper investigation of the disorder, assessment of environmental and biological factors, the conduction of treatment studies, and follow-up of the subjects.

NCT ID: NCT01000025 Completed - Lung Cancer Clinical Trials

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

Start date: December 23, 2009
Phase: Phase 3
Study type: Interventional

RATIONALE: PF-00299804 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether PF-00299804 is more effective than a placebo in treating patients with advanced non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying PF-00299804 to see how well it works compared with a placebo in treating patients with stage IIIB or stage IV non-small cell lung cancer that has not responded to standard therapy for advanced or metastatic cancer.

NCT ID: NCT00999648 Completed - Tinnitus Clinical Trials

Efficacy of Myofascial Trigger Point Pressure Release on Tinnitus Patients

MTP
Start date: March 2008
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the efficacy of myofascial trigger (MTP) point deactivation for tinnitus control in a population with tinnitus and myofascial pain.

NCT ID: NCT00999505 Unknown status - Schizophrenia Clinical Trials

Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia

Start date: May 2010
Phase: Phase 3
Study type: Interventional

Amantadine as add-on therapy to antipsychotics may improve schizophrenia positive, negative and cognitive symptoms.

NCT ID: NCT00999180 Active, not recruiting - Stroke Clinical Trials

Botulinum Toxin Type A and Kinesitherapy of Post-stroke Patients

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to assess if the association of botulinum toxin type A and kinesitherapy is superior to kinesitherapy and 0,9% saline for the functional performance in post-stroke patients. Hypothesis H(0): BT-A associated to kinesitherapy is not superior to kinesitherapy in the function of hemiparetic post-stroke patients. H(1): BT-A associated to kinesitherapy is superior to kinesitherapy in the function of hemiparetic post-stroke patients.

NCT ID: NCT00997737 Completed - Breathing Exercises Clinical Trials

Diaphragm Activity During Incentive Spirometry and Diaphragmatic Breathing

Start date: October 2009
Phase: Phase 1
Study type: Interventional

The objective of the present study is to evaluate diaphragm activity during three breathing exercises: diaphragmatic breathing (DB), flow-oriented (Triflo II)incentive spirometry and volume-oriented (Voldyne) incentive spirometry. Seventeen healthy subjects will be studied (8 man and 9 woman).

NCT ID: NCT00997295 Completed - General Anesthesia Clinical Trials

Heat and Moisture Exchanger and Low-flow Gas

Start date: January 2007
Phase: N/A
Study type: Observational

The aim of the present study was to measure the inspired gas temperature and humidity of the anesthetic circuit in the Dräger Primus machine and esophageal temperature with or without and heat and moisture exchanger (HME) and low-flow gas during anesthesia in patients submitted to gynecological surgeries.

NCT ID: NCT00997191 Completed - Clinical trials for Diabetic Macular Edema

Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)

IBeTA
Start date: October 2009
Phase: Phase 3
Study type: Interventional

Intravitreal triamcinolone has been effective for central macular thickness reduction and concomitant visual acuity improvement in patients with diabetic macular edema (DME). VEGF is a very effective inducer of permeability, being 50.000 times more potent than histamine, and may exert its effect on retinal vascular permeability by altering tight-junctions proteins, such as occluding and VE-cadherin. Based on these principles, there is a rationale for anti-VEGF agents treatment of increased retinal capillary permeability conditions, such as diabetic macular edema. Therefore, the purpose of this study is to evaluate the effects of intravitreal bevacizumab and intravitreal triamcinolone associated to laser photocoagulation for diabetic macular edema.